Mycobacterium Citations List: October 2024

Literature Citations

1. Synthesis and Biological Evaluation of Natural Lachnophyllum methyl ester, Lachnophyllum lactone and their Synthetic Analogs. Adande, K., O. Simalou, J. Ardanuy, K. Eloh, C. Mehalla, P. Constant, I. Fabing, Y. Génisson, and S. Ballereau. Organic and Biomolecular Chemistry, 2024. 22(39): p. 8010-8023. PMID[39257242].
[PubMed]. TB_10_2024.

2. Identification of Chemical Scaffolds that Inhibit the Mycobacterium tuberculosis Respiratory Complex Succinate dehydrogenase. Adolph, C., K. Hards, Z.C. Williams, C.Y. Cheung, L.M. Keighley, W.J. Jowsey, M. Kyte, D.K. Inaoka, K. Kita, J.S. Mackenzie, A.J.C. Steyn, Z. Li, M. Yan, G.B. Tian, T. Zhang, X. Ding, D.P. Furkert, M.A. Brimble, A.J.R. Hickey, M.B. McNeil, and G.M. Cook. ACS Infectious Diseases, 2024. 10(10): p. 3496-3515. PMID[39268963].
[PubMed]. TB_10_2024.

3. Revitalizing Antimicrobial Strategies: Paromomycin and Dicoumarol Repurposed as Potent Inhibitors of M.tb's Replication Machinery Via Targeting the Vital Protein DnaN. Ali, W., M. Agarwal, S. Jamal, R. Gangwar, R. Sharma, M.M. Mubarak, Z.A. Wani, Z. Ahmad, A. Khan, J.A. Sheikh, A. Grover, A. Bhaskar, V.P. Dwivedi, and S. Grover. International Journal of Biological Macromolecules, 2024. 278(Pt 3): 134652. PMID[39173789].
[PubMed]. TB_10_2024.

4. Synthesis, In Vitro Antimycobacterial Activity of Some 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-aryl-tetrahydropyridazin-3-one Derivatives. Allahyani, M., A. Alsharif, M. Almehmadi, S. Verma, and M. Asif. Pharmaceutical Chemistry Journal, 2024. ISI[001330459000005].
[WOS]. TB_10_2024.

5. Design and Synthesis of Novel Triazoloquinazolin-5(3H)-one Analogues as Promising Antitubercular Agents. Appani, R. and M. Sumakanth. Russian Journal of General Chemistry, 2024. 94(8): p. 2152-2166. ISI[001328966500020].
[WOS]. TB_10_2024.

6. New Tetrazole-annulated Pyrazolyl-pyrimidine Derivatives as Antimycobacterial Targets: Design, Synthesis, Molecular Docking, and ADME Profiling. Basireddy, A., S. Basireddy, T. Allaka, M. Afzal, and P. Kishore. Russian Journal of General Chemistry, 2024. 94(8): p. 2008-2017. ISI[001328966500023].
[WOS]. TB_10_2024.

7. Novel Benzothiophene‒tethered 1,3,4‒oxadiazoles as Potent Antimicrobial Targets: Design, Synthesis, Biological Evaluation, DFT Exploration and In Silico Docking Study. Bohurudeen, S.Z.B., A. Ambala, T.R. Allaka, M.Z. Ahmed, B. Thirunavukkarasu, R. Tirumalareddy, and S. Venkatesan. Journal of Molecular Structure, 2025. 1322: 140251. ISI[001336125800001].
[WOS]. TB_10_2024.

8. A Novel C-4-modified Isotetrone Acts as a Potent Bio-enhancer to Augment the Activities of Anti-tuberculosis Drugs against Mycobacterium tuberculosis. Bokolia, N.P., K. Bag, B. Sarkar, R. Jhawar, D. Chatterji, N. Jayaraman, and A. Ghosh. Tuberculosis, 2024. 149: 102569. PMID[39357126].
[PubMed]. TB_10_2024.

9. Organotin(IV) Complexes of Tridentate (ONO) Hydrazone Ligands: Synthesis, Spectral Characterization, Antituberculosis, Antimicrobial, Anti-inflammatory, Molecular Docking and Cytotoxicity Studies. Boora, A., J. Devi, B. Kumar, and B. Taxak. BioMetals, 2024. PMID[39373862].
[PubMed]. TB_10_2024.

10. Screening of Novel Narrow-spectrum Benzofuroxan Derivatives for the Treatment of Multidrug-resistant Tuberculosis through In Silico, In Vitro, and In Vivo Approaches. Campos, D.L., C.S.C. Canales, F.M. Demarqui, G.F.S. Fernandes, C.G. Dos Santos, J.L.B. Prates, I.G.M. da Silva, K.B. Barros-Cordeiro, S.N. Báo, L.N. de Andrade, N. Abichabki, L.V. Zacharias, M.M.A. de Campos, J.L. Dos Santos, and F.R. Pavan. Frontiers in Microbiology, 2024. 15: 1487829. PMID[39464394]. PMCID[PMC11502347].
[PubMed]. TB_10_2024.

11. Design, Synthesis, Evaluation of Antitubercular Activity and Insilco Studies of Novel 1,5-naphthyridin-2(1H)-one Pendent 1,2,3-triazoles. Chilakala, N.B., A. Roy, N.P. Kalia, V. Thumma, B. Raju, S. Etnoori, and K. Premalatha. Chemistry & Biodiversity, 2024. ISI[001337801500001].
[WOS]. TB_10_2024.

12. Synthesis and Anti-bacterial Activity of New Substituted 2-trifluoromethyl-4-quinolinylhydrazone Analogs against Mycobacterium tuberculosis Strains. da Silva, E.T., G.F. de Andrade, M.C.S. Lourenço, and M.V.N. De Souza. Current Medicinal Chemistry, 2024. 31(40): p. 6713-6721. PMID[39420718].
[PubMed]. TB_10_2024.

13. The Novel Drug Candidate VOMG Kills Mycobacterium abscessus and Other Pathogens by Inhibiting Cell Division. Degiacomi, G., L.R. Chiarelli, O. Riabova, N.I. Loré, L. Muñoz-Muñoz, D. Recchia, G. Stelitano, U. Postiglione, F. Saliu, A. Griego, V.C. Scoffone, E. Kazakova, E. Scarpa, J.M. Ezquerra-Aznárez, A. Stamilla, S. Buroni, E. Tortoli, L. Rizzello, D. Sassera, S. Ramón-García, D.M. Cirillo, V. Makarov, and M.R. Pasca. International Journal of Antimicrobial Agents, 2024. 64(4): 107278. PMID[39069229].
[PubMed]. TB_10_2024.

14. Synthesis, Antitubercular Evaluation of New 2,3-(4-aminobenzamido)benzoic acid Derivatives. Dudhe, P.B., S.P. Dudhe, M.K. Kathiravan, and H.G. Bhatt. Russian Journal of Bioorganic Chemistry, 2024. 50(5): p. 1822-1837. ISI[001337204100014].
[WOS]. TB_10_2024.

15. Chemical Composition and Antimicrobial Investigation of the Essential Oil Isolated from Montanoa Bipinnatifida (Kunth) K. Koch Leaves. El-Nashar, H.A.S., A.M. Abbas, A.M. Al-Qaaneh, M.A. Abdel-Maksoud, M.A. El-Tayeb, S. Almutairi, B.H. Kiani, and E.A. Elhawary. Journal of Essential Oil Bearing Plants, 2024. ISI[001331216600001].
[WOS]. TB_10_2024.

16. Design and Synthesis of Isatin-tagged Isoniazid Conjugates with Cogent Antituberculosis and Radical Quenching Competence: In-vitro and In-silico Evaluations. Gavadia, R., J. Rasgania, N. Sahu, M. Varma-Basil, V. Chauhan, S. Kumar, S. Mor, D. Singh, and K. Jakhar. Chemistry & Biodiversity, 2024. 21(10): e202400765. PMID[39024129].
[PubMed]. TB_10_2024.

17. Synthesis, Structural, DFT Studies, Biological Effectiveness, and Molecular Docking Aspects of Multitarget Novel N-(4-phenylthiazol-2-yl)hydrazine Carboxamide Hybrids as COX Inhibitors, Anti-TB, and Anti-oxidant Activity. Hiremath, B., A. Maurya, G. Nagesh, O. Prasad, P. Karunakar, L. Sinha, M. Ahmed, and S. Basavarajaiah. Journal of Molecular Structure, 2025. 1321: 140081. ISI[001324362900001].
[WOS]. TB_10_2024.

18. Design and Synthesis of Thieno[3, 2-B]pyridinone Derivatives Exhibiting Potent Activities against Mycobacterium Tuberculosis In Vivo by Targeting Enoyl-ACP Reductase. Liang, L., Z. Liu, J. Chen, Q. Zha, Y. Zhou, J. Li, Y. Hu, X. Chen, T. Zhang, and N. Zhang. European Journal of Medicinal Chemistry, 2024. 279: 116806. PMID[39276583].
[PubMed]. TB_10_2024.

19. Synthesis, Spectral Analysis, Antimicrobial Evaluation, Molecular Modelling, DFT, TD-DFT and SAR Studies of Novel 4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole Derivatives. Maiti, N.J. and S. Ganguly. ChemistrySelect, 2024. 9(36): e202401746. ISI[001318771000001].
[WOS]. TB_10_2024.

20. Antifungal and Antibacterial Activities of Crude Extracts of Four Phellinus Species and Coltricia fragilissima (Agaricomycetes) from Cameroon and Democratic Republic of Congo. Metsebing, B.P., R. Oba, F.T. Tsigain, T.Y. Fonkui, M.C.D. Fotsing, T.C. Mungoh, D.N. Ndinteh, and D.C. Mossebo. International Journal of Medicinal Mushrooms, 2024. 26(10): p. 9-18. PMID[39171628].
[PubMed]. TB_10_2024.

21. Design, Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Analgesic and Anti-inflammatory Agents: Experimental and Molecular Docking Insights. Muheyuddeen, G., M.Y. Khan, T. Ahmad, S. Srivastava, S. Verma, M.S. Ansari, and N. Sahu. Scientific Reports, 2024. 14(1): 23121. PMID[39367036]. PMCID[PMC11452658].
[PubMed]. TB_10_2024.

22. Synthesis and InhA Inhibition of Imidazo[1,2-a]pyridine Derivatives as Anti-tuberculosis Agents. Patel, T., N.F. Chauhan, V.D. Bhatt, B.S. Bhatt, R. Senta, D.S. Shah, A. Patel, A. Chokshi, U.M. Shah, and M. Patel. Current Organic Chemistry, 2024. ISI[001326703500001].
[WOS]. TB_10_2024.

23. Berberine Enhances the Antibacterial Activity of Thymoquinone, Carvacrol and Thymol against Multi-drug Resistant Nontuberculous Mycobacteria. Puk, K., L. Guz, and A. Pastuszka. Polish Journal of Veterinary Sciences, 2024. 27(3): p. 469-473. ISI[001318490900016].
[WOS]. TB_10_2024.

24. Synergistic Oral Beta-lactam Combinations for Treating Tuberculosis. Quan, D.H., T. Wang, E. Martinez, H.Y. Kim, V. Sintchenko, W.J. Britton, J.A. Triccas, and J.C. Alffenaar. Journal of Applied Microbiology, 2024. 135(10). PMID[39394664].
[PubMed]. TB_10_2024.

25. Design, Synthesis and Docking Studies of New Molecular Hybrids Bearing Benzimidazole and Thiazolidine-2,4-Dione as Potential Antitubercular Agents. Raghu, M.S., A.Y. Jassim, C.B.P. Kumar, K.Y. Kumar, M.K. Prashanth, F. Alharethy, and B.H. Jeon. Journal of the Indian Chemical Society, 2024. 101(10): 101346. ISI[001317012800001].
[WOS]. TB_10_2024.

26. Design and Synthesis of Isoniazid-based Pyrazolines as Potential Inhibitors of Mycobacterium tuberculosis with Promising Radical Scavenging Action: In-vitro and In-silico Evaluations. Rasgania, J., R. Gavadia, M. Varma-Basil, V. Chauhan, S. Kumar, S. Mor, D. Singh, and K. Jakhar. Journal of Molecular Structure, 2024. 1295: 136657. ISI[001336369900001].
[WOS]. TB_10_2024.

27. 2-aryl-benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis. Saha, P., S. Sau, N.P. Kalia, and D.K. Sharma. ACS Infectious Diseases, 2024. 10(10): p. 3699-3711. PMID[39360674].
[PubMed]. TB_10_2024.

28. Bioassay-guided Isolation and Structure Elucidation of Anti-mycobacterium tuberculosis Compounds from Galatella grimmii (Regel & Schmalh.) Sennikov. Shakeri, A., M. Tajvar, G.T. Tabrizi, S. Soleimanpour, J. Davoodi, J. Asili, M.S. Amiri, and S.A. Emami. BMC Complementary Medicine and Therapies, 2024. 24(1): p. 345. PMID[39354550]. PMCID[PMC11443940].
[PubMed]. TB_10_2024.

29. Rational Design and Microwave-promoted Synthesis of Triclosan-based Dimers: Targeting InhA for Anti-mycobacterial Profiling. Shekhar, F. Roquet-Banères, A. Anand, L. Kremer, and V. Kumar. Royal Society Open Science, 2024. 11(10): 240676. PMID[39392739]. PMCID[PMC11461061].
[PubMed]. TB_10_2024.

30. Synthesis and Evaluation of the Anti-TB Activity of Novel 7-(2-(4-substituted-phenyl)-4,5-diphenyl-1H-imidazol-1-yl)-4-methyl-2H-chromen-2-one Derivatives and their DFT Studies for NLO Application. Surendranaik, Y. and T. Venkatesh. Journal of Molecular Structure, 2025. 1321: 140111. ISI[001335311000001].
[WOS]. TB_10_2024.

Patent Citations

This month, no relevant Mycobacterium patents were identified.